Is clinical trial data showing positive progress for the treatment of diabetic kidney disease?

Click to increase image sizeClick to decrease image size

Declaration of interest

M E Cooper has received honorarium from companies making anti-diabetic drugs including AstraZeneca, Novo Nordisk, Boehringer Ingelheim, and Eli Lilly. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.